$0.6405
0.00550.87%
In chiusura: Nov 21, 4:00 PM EST
Comments
Loading...
Report sulle vendite allo scoperto
Il short interest su Brainstorm Cell Therapeutics Inc (OTC:BCLI) è diminuito durante l'ultimo periodo di rilevazione, aumentando da 280.13K a 276.96K. Questo rappresenta il 2.88% delle azioni disponibili pubblicamente dell'azienda.
Sulla base del volume medio recente di 31.30K azioni scambiate al giorno, ci vorrebbero 8.85 giorno(i) per chiudere le posizioni di questo interesse a breve senza spingere fortemente al rialzo il titolo.
Vendite allo scoperto
276.96K
Vendite allo scoperto %
2.88%
Giorni di copertura
8.85
Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|
BCLI | Brainstorm Cell Therapeutics I | 10/31/2025 | 11/11/2025 | 2.88% | 9,618,726 | 276,965 | 31,300 | 8.85 | |
BCLI | Brainstorm Cell Therapeutics I | 10/15/2025 | 10/24/2025 | 2.91% | 9,618,726 | 280,130 | 44,471 | 6.3 | |
BCLI | Brainstorm Cell Therapeutics I | 09/30/2025 | 10/09/2025 | 3.12% | 9,618,726 | 300,362 | 45,421 | 6.61 | |
BCLI | Brainstorm Cell Therapeutics I | 09/15/2025 | 09/24/2025 | 3.40% | 9,618,726 | 327,152 | 39,898 | 8.2 | |
BCLI | Brainstorm Cell Therapeutics I | 08/29/2025 | 09/10/2025 | 3.56% | 9,618,726 | 342,635 | 61,190 | 5.6 | |
BCLI | Brainstorm Cell Therapeutics I | 08/15/2025 | 08/26/2025 | 3.62% | 9,618,726 | 348,234 | 156,516 | 2.22 | |
BCLI | Brainstorm Cell Therapeutics I | 07/31/2025 | 08/11/2025 | 4.75% | 9,081,476 | 431,321 | 614,484 | 1 | |
BCLI | Brainstorm Cell Therapeutics I | 07/15/2025 | 07/24/2025 | 6.24% | 9,081,476 | 566,390 | 422,865 | 1.34 | |
BCLI | Brainstorm Cell Therapeutics I | 06/30/2025 | 07/10/2025 | 6.66% | 9,081,476 | 604,460 | 449,766 | 1.34 | |
BCLI | Brainstorm Cell Therapeutics I | 06/13/2025 | 06/25/2025 | 6.45% | 7,181,493 | 463,315 | 430,860 | 1.08 | |
BCLI | Brainstorm Cell Therapeutics I | 05/30/2025 | 06/10/2025 | 7.48% | 7,181,493 | 536,937 | 6,614,599 | 1 | |
BCLI | Brainstorm Cell Therapeutics I | 05/15/2025 | 05/27/2025 | 2.92% | 7,181,493 | 209,504 | 117,744 | 1.78 | |
BCLI | Brainstorm Cell Therapeutics I | 04/30/2025 | 05/09/2025 | 5.39% | 5,405,805 | 291,418 | 157,119 | 1.85 | |
BCLI | Brainstorm Cell Therapeutics I | 04/15/2025 | 04/25/2025 | 6.41% | 5,405,805 | 346,646 | 610,656 | 1 | |
BCLI | Brainstorm Cell Therapeutics I | 03/31/2025 | 04/09/2025 | 2.54% | 5,405,805 | 137,216 | 46,715 | 2.94 | |
BCLI | Brainstorm Cell Therapeutics I | 03/14/2025 | 03/25/2025 | 2.27% | 5,405,805 | 122,765 | 16,867 | 7.28 | |
BCLI | Brainstorm Cell Therapeutics I | 02/28/2025 | 03/11/2025 | 1.98% | 5,405,805 | 107,230 | 37,546 | 2.86 | |
BCLI | Brainstorm Cell Therapeutics I | 02/14/2025 | 02/26/2025 | 2.05% | 5,405,805 | 110,846 | 32,897 | 3.37 | |
BCLI | Brainstorm Cell Therapeutics I | 01/31/2025 | 02/11/2025 | 1.69% | 5,405,805 | 91,385 | 63,905 | 1.43 | |
BCLI | Brainstorm Cell Therapeutics I | 01/15/2025 | 01/27/2025 | 3.20% | 5,405,805 | 172,989 | 57,202 | 3.02 | |
BCLI | Brainstorm Cell Therapeutics I | 12/31/2024 | 01/10/2025 | 1.73% | 5,405,805 | 93,267 | 159,130 | 1 | |
BCLI | Brainstorm Cell Therapeutics I | 12/13/2024 | 12/24/2024 | 2.82% | 5,405,805 | 152,370 | 85,033 | 1.79 | |
BCLI | Brainstorm Cell Therapeutics I | 11/29/2024 | 12/10/2024 | 2.74% | 5,405,805 | 148,229 | 99,445 | 1.49 | |
BCLI | Brainstorm Cell Therapeutics I | 11/15/2024 | 11/26/2024 | 3.22% | 5,405,805 | 173,850 | 162,693 | 1.07 | |
BCLI | Brainstorm Cell Therapeutics I | 10/31/2024 | 11/11/2024 | 2.19% | 5,017,985 | 109,802 | 87,664 | 1.25 | |
BCLI | Brainstorm Cell Therapeutics I | 10/15/2024 | 10/24/2024 | 3.31% | 5,017,985 | 165,892 | 87,883 | 1.89 | |
BCLI | Brainstorm Cell Therapeutics I | 09/30/2024 | 10/09/2024 | 37.24% | 5,017,985 | 1,868,815 | 387,661 | 4.82 | |
BCLI | Brainstorm Cell Therapeutics I | 09/13/2024 | 09/24/2024 | 1.86% | 75,269,777 | 1,399,016 | 229,978 | 6.08 | |
BCLI | Brainstorm Cell Therapeutics I | 08/30/2024 | 09/11/2024 | 1.71% | 75,269,777 | 1,286,721 | 290,915 | 4.42 | |
BCLI | Brainstorm Cell Therapeutics I | 08/15/2024 | 08/26/2024 | 2.15% | 75,269,777 | 1,617,894 | 673,587 | 2.4 | |
BCLI | Brainstorm Cell Therapeutics I | 07/31/2024 | 08/09/2024 | 1.39% | 76,836,964 | 1,065,531 | 362,829 | 2.94 | |
BCLI | Brainstorm Cell Therapeutics I | 07/15/2024 | 07/24/2024 | 1.41% | 76,836,964 | 1,080,538 | 533,231 | 2.03 | |
BCLI | Brainstorm Cell Therapeutics I | 06/28/2024 | 07/10/2024 | 2.13% | 68,918,200 | 1,468,709 | 716,077 | 2.05 | |
BCLI | Brainstorm Cell Therapeutics I | 06/14/2024 | 06/26/2024 | 1.32% | 67,335,703 | 890,588 | 793,969 | 1.12 | |
BCLI | Brainstorm Cell Therapeutics I | 05/31/2024 | 06/11/2024 | 1.67% | 67,335,703 | 1,121,353 | 497,781 | 2.25 | |
BCLI | Brainstorm Cell Therapeutics I | 05/15/2024 | 05/24/2024 | 2.10% | 67,335,703 | 1,414,121 | 805,129 | 1.76 | |
BCLI | Brainstorm Cell Therapeutics I | 04/30/2024 | 05/09/2024 | 3.20% | 65,597,037 | 2,098,310 | 570,888 | 3.68 | |
BCLI | Brainstorm Cell Therapeutics I | 04/15/2024 | 04/24/2024 | 3.04% | 65,597,037 | 1,991,679 | 1,382,034 | 1.44 | |
BCLI | Brainstorm Cell Therapeutics I | 03/28/2024 | 04/09/2024 | 2.05% | 65,597,037 | 1,343,163 | 1,894,389 | 1 | |
BCLI | Brainstorm Cell Therapeutics I | 03/15/2024 | 03/26/2024 | 1.82% | 46,641,147 | 850,265 | 518,858 | 1.64 | |
BCLI | Brainstorm Cell Therapeutics I | 02/29/2024 | 03/11/2024 | 2.29% | 46,641,147 | 1,067,002 | 804,804 | 1.33 | |
BCLI | Brainstorm Cell Therapeutics I | 02/15/2024 | 02/27/2024 | 2.65% | 46,641,147 | 1,234,664 | 795,127 | 1.55 | |
BCLI | Brainstorm Cell Therapeutics I | 01/31/2024 | 02/09/2024 | 4.36% | 46,641,147 | 2,034,743 | 796,006 | 2.56 | |
BCLI | Brainstorm Cell Therapeutics I | 01/12/2024 | 01/24/2024 | 5.12% | 46,641,147 | 2,386,380 | 1,077,964 | 2.21 | |
BCLI | Brainstorm Cell Therapeutics I | 12/29/2023 | 01/10/2024 | 9.02% | 46,641,147 | 4,209,007 | 4,318,485 | 1 | |
BCLI | Brainstorm Cell Therapeutics I | 12/15/2023 | 12/27/2023 | 7.20% | 46,641,147 | 3,357,336 | 4,893,971 | 1 | |
BCLI | Brainstorm Cell Therapeutics I | 11/30/2023 | 12/11/2023 | 7.51% | 46,641,147 | 3,500,593 | 3,994,582 | 1 | |
BCLI | Brainstorm Cell Therapeutics I | 11/15/2023 | 11/27/2023 | 8.09% | 46,641,147 | 3,772,910 | 1,035,083 | 3.65 |
In cerca di azioni più vendute allo scoperto?